Pharmacist intervention through protocol-based pharmacotherapy management is effective to ensure safety in invasive procedures for chronic liver disease
The use of platelet products decreases without the increased incidences of hemorrhage if pharmacists suggest prescribing thrombopoietin receptor agonists based on their assessment of the platelet count and the bleeding risk of the procedure.
Authors
- Kensuke Naruto (ORCID: https://orcid.org/0000-0003-1128-0960)
- Kei Amioka (ORCID: https://orcid.org/0000-0002-6658-5203)
- Eisuke Murakami (ORCID: https://orcid.org/0000-0003-0357-2795)
- Masataka Tsuge (ORCID: https://orcid.org/0000-0001-7591-8287)
- Tomokazu Kawaoka (ORCID: https://orcid.org/0000-0002-1887-1096)
- Tomoharu Yokooji (ORCID: https://orcid.org/0000-0002-2535-6295)
- Emiko Mashida
- Yusuke Johira (ORCID: https://orcid.org/0000-0002-4521-5887)
- Takanori Taogoshi
- Yuuka Shibata (ORCID: https://orcid.org/0000-0003-4493-9696)
- Hiroaki Matsuo (ORCID: https://orcid.org/0000-0002-8730-5389)
- Yuki Sato (ORCID: https://orcid.org/0000-0002-8986-8388)
- Yuki Koga
Institutions
- Hiroshima University (JP)
- Hiroshima University Hospital (JP)
Publication Details
- Journal
- Journal of Pharmaceutical Health Care and Sciences
- Published
- 2025-08-14
- DOI
- https://doi.org/10.1186/s40780-025-00456-z
- Citations
- 1
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 1.32